THERAKOS CELLEX PHOTOPHERESIS SYSTEMS
FDA premarket approval P860003/S062 · decided 2011-10-28
Approval details
- PMA number
- P860003
- Supplement
- S062
- Supplement type
- Special (Immediate Track)
- Supplement reason
- Labeling Change - Indications/instructions/shelf life/tradename
- Trade name
- THERAKOS CELLEX PHOTOPHERESIS SYSTEMS
- Generic name
- System, photopheresis, extracorporeal
- Applicant
- Therakos Development Limited
- Date received
- 2011-09-29
- Decision date
- 2011-10-28
- Days to decision
- 29 days
- Decision code
- APPR
- Product code
- LNR
- Advisory committee
- Gastroenterology, Urology
- Expedited review
- No
- Location
- Dublin
- Statement
- APPROVAL FOR A TECHNICAL BULLETIN THAT WILL BE SENT OUT TO USERS OF THE CELLEX¿ SYSTEM.
Class III intelligence, same tools
PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.